Delivery Order SPE2DB22D2005-SPE2DB25FJSH3
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,251.60 on August 15, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The contract, designated as a firm fixed price delivery order with an ultimate completion date of August 18, 2025, represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $22,877.40 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999. The delivery location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $17,506.81 on August 20, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectable medication, with final completion scheduled for August 21, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,575.54 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The order, which represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical, is scheduled for completion by September 16, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was...
- The Defense Logistics Agency awarded a $9,847.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The delivery order is non-competitive and carries an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $15,472.34. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,509.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on August 19, 2025, with ultimate completion scheduled for August 20, 2025. This competitive award, placed under no set-aside designation, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement...
- The Defense Logistics Agency awarded a delivery order valued at $22,447.88 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order represents a single transaction...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,143.16 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under AmerisourceBergen's larger...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSH3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on August 21, 2025, with a ceiling value of $6,243.72 and a completion date of August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location in the same city. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio for federal medical procurement, which includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities serving military and veteran healthcare systems. The company's IDC with DLA Troop Support Medical serves as a global pharmaceutical support vehicle enabling delivery of diverse medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award of Zepbound, a diabetes medication, reflects the company's established capability to fulfill federal medical supply requirements through open competition and firm fixed price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 8/21/25 |